Objective : The Cosgrove-Edwards Annuloplasty System (CEAS®) can be used both in the mitral and in the tricuspid position. Moreover, the implantation of an incomplete flexible ring in tricuspid valve repair, is less likely to jeopardize the conduction system. This study was undertaken to evaluate the efficacy of the (CEAS®) in the tricuspid position on a short-term basis.
Methods : From Septembre 1997 to December 2001, 62 patients with functional tricuspid regurgitation underwent an annuloplasty with the (CEAS®). Mean tricuspid regurgitation grade was 3,21/4 preoperatively. Except for 1 patient, all had associated left sided valve surgery. There were 19 double valve replacements, 33 mitral valve replacements, 4 mitral valve repairs and 5 aortic valve replacements. 24 patients (38,7%) had undergone previous valve surgery. Mean age was 46,6 years. 58 patients (93,5%) were in New York Heart Association functional class 3 or 4. Severe pulmonary hypertension was present in 39 patients (62,9%).
Results : The in-hospital mortality was 11,3%. There were 3 nonvalve related cardiac deaths and 4 noncardiac related deaths. Mean grade of residual tricuspid regurgitation was 1,26/4 (p<0.001) postoperatively. Pulmonary hypertension persisted in 14 patients (35,9%) (p<0,001). One patient presented a de novo third degree A-V block. Freedom from early tricuspid valve reoperation was 95,1%.
Conclusion : The (CEAS®) is a safe, simple and effective option for controling functional tricuspid regurgitation in patients with multiple valve diseases. The grade of regurgitation is reliably improved.